Chronology and Sequence of Premonitory Symptoms
ConditionMigraine
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorUniversity of Roma La Sapienza
About this trial
The purpose of this study is to prospectively investigate the temporal sequence of premonitory symptoms across multiple migraine attacks.
Eligibility criteria
Qualifiers
Diagnosis of episodic (EM) or chronic migraine (CM) or CM with medication overuse headache (MOH) according to ICHD-III criteria;
Age between 18 and 65 years;
At least 2 migraine days (MMD) in the month preceding the inclusion;
Migraine history of at least 12 months prior to inclusion
Disqualifiers
History or current diagnosis of secondary headache disorders as defined by ICHD-III;
History of other neurological comorbidities or major psychiatric disorders;
History of migraine for < 12 months prior to the inclusion;
Opioid overuse according to the ICHD-III criteria;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
500 Participants
are grouped into 1 trial groupSponsors and collaborators
University of Roma La Sapienza
Lead sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Collaborator
University of Modena and Reggio Emilia
Collaborator
University of Bari
Collaborator
Campus Bio-Medico University
Collaborator
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
Collaborator
Azienda USL Ferrara
Collaborator
University of Florence
Collaborator
Azienda Ospedaliero-Universitaria Careggi
Collaborator
Azienda Ospedaliero Universitaria Policlinico Modena
Collaborator
Ospedale di Piove di Sacco
Collaborator
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborator
Cliniche Humanitas Gavazzeni
Collaborator
Carlo Besta Neurological Institute
Collaborator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborator
Source ClinicalTrials.gov